Alice B Kornblith

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Cancer-related communication between female patients and male partners scale: A pilot study
    Alice B Kornblith
    Women s Cancers Program D 1210, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Psychooncology 15:780-94. 2006
  2. ncbi request reprint Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study
    Alice B Kornblith
    Women s Cancers Program, Dana Farber Cancer Institute, Rm D1210, 44 Binney Street, Boston, MA 02115, USA
    J Clin Oncol 20:2441-52. 2002
  3. ncbi request reprint Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials
    Alice B Kornblith
    Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 95:989-96. 2002
  4. ncbi request reprint Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy
    Alice B Kornblith
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 98:679-89. 2003
  5. ncbi request reprint Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer
    Alice B Kornblith
    Breast Oncology Program Mayer 2, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Psychooncology 16:895-903. 2007
  6. pmc Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study
    Alice B Kornblith
    Division of Women s Cancers, Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 27:5337-42. 2009
  7. pmc Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907
    Alice B Kornblith
    Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 29:1022-8. 2011
  8. ncbi request reprint Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study
    Alice B Kornblith
    Breast Oncology Program, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 107:2706-14. 2006
  9. doi request reprint Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Breast Cancer Res Treat 139:607-16. 2013
  10. pmc Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104
    Ann H Partridge
    Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    J Clin Oncol 28:2418-22. 2010

Detail Information

Publications26

  1. ncbi request reprint Cancer-related communication between female patients and male partners scale: A pilot study
    Alice B Kornblith
    Women s Cancers Program D 1210, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Psychooncology 15:780-94. 2006
    ....
  2. ncbi request reprint Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study
    Alice B Kornblith
    Women s Cancers Program, Dana Farber Cancer Institute, Rm D1210, 44 Binney Street, Boston, MA 02115, USA
    J Clin Oncol 20:2441-52. 2002
    ..The impact of azacytidine (Aza C) on the quality of life of 191 patients with myelodysplastic syndrome was assessed in a phase III Cancer and Leukemia Group B trial (9221)...
  3. ncbi request reprint Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials
    Alice B Kornblith
    Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 95:989-96. 2002
    ....
  4. ncbi request reprint Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy
    Alice B Kornblith
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 98:679-89. 2003
    ....
  5. ncbi request reprint Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer
    Alice B Kornblith
    Breast Oncology Program Mayer 2, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Psychooncology 16:895-903. 2007
    ..The study's objective was to test whether there were signfiicant differences in adjustment between younger and older breast and endometrial cancer survivors...
  6. pmc Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study
    Alice B Kornblith
    Division of Women s Cancers, Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 27:5337-42. 2009
    ..The study's objective was to compare the quality of life (QoL) of patients with endometrial cancer undergoing surgical staging via laparoscopy versus laparotomy...
  7. pmc Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907
    Alice B Kornblith
    Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 29:1022-8. 2011
    ..The quality of life (QoL) substudy tested whether capecitabine treatment would be associated with a better QoL than standard chemotherapy...
  8. ncbi request reprint Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study
    Alice B Kornblith
    Breast Oncology Program, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 107:2706-14. 2006
    ....
  9. doi request reprint Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Breast Cancer Res Treat 139:607-16. 2013
    ..In a healthy group of older women, chemotherapy was not associated with longitudinal changes in self-reported cognitive function...
  10. pmc Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104
    Ann H Partridge
    Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    J Clin Oncol 28:2418-22. 2010
    ..Patient adherence is critical in evaluating the effectiveness of an oral therapy. We sought to measure adherence among women randomly assigned to capecitabine in a preplanned substudy of a multicenter clinical trial...
  11. pmc Measuring psychosocial distress and parenting concerns among adults with cancer: the Parenting Concerns Questionnaire
    Anna C Muriel
    Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Cancer 118:5671-8. 2012
    ..Limited information about this area of psychosocial distress highlights the need for a measurement tool that can identify adult oncology patients with heightened parenting concerns who could benefit from additional intervention...
  12. doi request reprint Comparison of the quality of life of early and advanced stage ovarian cancer survivors
    Kristina L Mirabeau-Beale
    Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 114:353-9. 2009
    ..The objective of this study was to compare the long-term adjustment and QOL of early and advanced stage ovarian cancer survivors (OCS)...
  13. ncbi request reprint Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066
    Jeffrey Peppercorn
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 104:1580-9. 2005
    ..The patients were randomized to receive either high-dose chemotherapy with autologous stem cell support (HDC) or intermediate-dose chemotherapy (IDC) in the adjuvant setting...
  14. ncbi request reprint Psychosocial and sexual functioning of survivors of breast cancer
    Alice B Kornblith
    Women s Cancers Program, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Semin Oncol 30:799-813. 2003
    ..Those with long-term medical sequelae, such as lymphedema, have worse adjustment compared to those who do not. Future research directions are suggested...
  15. ncbi request reprint Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
    Lewis R Silverman
    Division of Medical Oncology, Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center, Box 1129, One Gustave L Levy Place, New York, NY 10029, USA
    J Clin Oncol 20:2429-40. 2002
    ..Supportive care is standard therapy. We previously reported that azacitidine (Aza C) was active in patients with high-risk MDS...
  16. ncbi request reprint Barriers to clinical trial participation by older women with breast cancer
    M Margaret Kemeny
    Cancer and Leukemia Group B and the University ofChicago Medical Center, IL, USA
    J Clin Oncol 21:2268-75. 2003
    ..This study tested whether older patients were offered trials significantly less often than younger patients and whether older patients who were offered trials were more likely to refuse participation than younger patients...
  17. ncbi request reprint Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001
    Gretchen G Kimmick
    Duke University Medical Center, Suite 3800 Duke S, Box 3204, Durham, NC 27710, USA
    J Clin Oncol 23:2201-7. 2005
    ..To design and test a geriatric educational intervention to improve accrual of cancer patients age 65 years and older to cooperative group-sponsored treatment trials...
  18. ncbi request reprint Developing a cancer-specific geriatric assessment: a feasibility study
    Arti Hurria
    Department of Medicine, Psychiatry and Behavioral Sciences, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 104:1998-2005. 2005
    ....
  19. ncbi request reprint Funding patient-reported outcomes in cancer clinical trials
    Carol M Moinpour
    Southwest Oncology Group Statistical Center Fred Hutchinson Cancer Research Center, Seattle, WA 98104 1024, USA
    J Clin Oncol 25:5100-5. 2007
    ....
  20. doi request reprint Pain predicts overall survival in men with metastatic castration-refractory prostate cancer
    Susan Halabi
    Department of Biostatistics and Bioinformatics, Duke University, and Cancer and Leukemia Group B Statistical Center, Durham, NC, USA
    J Clin Oncol 26:2544-9. 2008
    ..The objective of this study was to determine whether men with CRPC who had higher pain interference scores at baseline had worse clinical outcomes compared with men who had lower pain scores...
  21. doi request reprint Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer
    Andrea L Cheville
    Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
    J Clin Oncol 26:2621-9. 2008
    ..We studied these issues by quantifying physical impairments in patients with metastatic breast cancer and by assessing how they are addressed...
  22. ncbi request reprint Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks
    Deborah Watkins Bruner
    Radiation Therapy Oncology Group, University of Pennsylvania, School of Nursing American College of Radiology Imaging Network, Philadelphia, PA 19104 6096, USA upenn edu
    J Clin Oncol 25:5051-7. 2007
    ..The objective of this report is to provide a historical overview of and the issues and challenges inherent in the incorporation of patient-reported outcomes (PROs) into multinational cancer clinical trials in the cancer cooperative groups...
  23. ncbi request reprint Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480
    Tim A Ahles
    Norris Cotton Cancer Center, Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    Cancer 101:2202-8. 2004
    ..The primary purpose of the current study was to evaluate whether there was evidence of palliative effects associated with suramin at any of the three doses administered in the original clinical trial...
  24. ncbi request reprint Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133
    Patricia A Ganz
    University of California, Los Angeles, Los Angeles, CA, USA
    J Clin Oncol 21:3512-9. 2003
    ....
  25. ncbi request reprint The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer
    Andrew J Roth
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 97:2910-8. 2003
    ..This scale consists of three subscales that measure general prostate cancer anxiety, anxiety related to prostate specific antigen (PSA) levels in particular, and fear of recurrence...
  26. ncbi request reprint Geriatric assessment for oncologists: rationale and future directions
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Rev Oncol Hematol 59:211-7. 2006
    ..Our eventual goal is to determine if this geriatric assessment measure can identify factors independent of age that predict cancer treatment morbidity and mortality and result in rationale interventions to optimize oncologic care...